06998.HK
Genor Biopharma Holdings Limited
HKSE · Healthcare · Biotechnology · CN
HKD 1.69
+2.42%Margins
Gross margin
64.7%
EBITDA margin
31.6%
EBIT margin
28.8%
Net margin
14.8%
FCF margin
6.4%
23.6%
Return on equity
15.4%
Return on assets
35.4%
Return on invested capital
1.00x
Asset turnover
HKD 526.5M
Cash from operations
HKD 0.64
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026